EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The GnRH Agonist Triptorelin Causes Reversible, Focal, and Partial Testicular Atrophy in Rats, Maintaining Sperm Production

Alberto Marcos iD, Maria Cruz Rodríguez Del Cerro, Rosa María Fernández iD, Eduardo Pásaro iD, Nuria Arias-Ramos iD, Pilar López-Larrubia iD, Pilar González-Peramato, Antonio Guillamon, Maria P De Miguel iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alberto Marcos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychobiology, Universidad Nacional de Educación a Distancia, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Triptorelin Pamoate, Testis, Gonadotropin-Releasing Hormone, Spermatogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science., Spanish Ministry of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aim to provide a translational model to investigate the reproductive consequences of pubertal delay using the GnRH agonist triptorelin in transgender girls, tested in particular on testicular maturation in peripubertal rats. A total of 30 Sprague Dawley rats were utilized, with 10 subjects assigned to each of three groups from day P30 postpartum (prepubertal) until day P95 (postpubertal), mimicking treatment timing in patients. Rats received triptorelin at three time points (P30, P50, and P71), or only at P30 and P50. Control rats were injected with vehicle. Plasma testosterone levels were determined using MRM analysis. Testes and epididymides were examined histologically. There were significantly lower testosterone levels at postnatal day 48 in treated rats, indicating delayed puberty, with further reductions by day 69. By day 93, testosterone levels had recovered in rats given vehicle at P71 but remained low in the triptorelin-continuous group, suggesting the reversibility of the treatment. Treated rats had smaller testes; however, the majority of the testicular parenchyma was unaffected, with most seminiferous tubules displaying complete spermatogenesis. However, focal atrophic changes were observed in 1–30% of the parenchyma. One-third of the short-term group and half of the long-term group were classified as atrophic. Despite these changes, all treated rats had mature sperm in the epididymis, ensuring their fertility. In conclusion, triptorelin treatment promotes a decline in testosterone levels accompanied by discrete atrophy of the seminiferous tubules, which is partially reversible and compatible with sperm production and fertility preservation. Triptorelin could be an appropriate treatment prior to estrogen therapy for patients seeking gender transition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triptorelin PamoateTestisGonadotropin-Releasing HormoneSpermatogenesisSpermatozoaAnimalsMaleRatsRats, Sprague-DawleyAtrophyTestosteroneSexual Maturation

Stichwörter der Autor:innen

GnRH agonistsfertilityrat testestransgender girlstriptorelin

Substanzen

Triptorelin PamoateGonadotropin-Releasing HormoneTestosterone

Autor:innen und Institutionen

  • Department of Psychobiology, Universidad Nacional de Educación a Distancia, 28040 Madrid, Spain.
  • Department of Psychology, Interdisciplinary Center for Chemistry and Biology Institute (CICA), DICOMOSA Group, University of A Coruña, 15190 A Coruña, Spain.
  • Department of Psychology, Institute for Biomedical Research of A Coruña (INIBIC), 15006 A Coruña, Spain.
  • Biomedical Magnetic Resonance, Instituto de Investigaciones Biomédicas Sols-Morreale, CSIC-UAM, 28029 Madrid, Spain.
  • Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Cell Engineering Laboratory, La Paz University Hospital Health Research Institute (IdiPAZ), 28046 Madrid, Spain.

ORCID-Profile: Alberto Marcos, Rosa María Fernández, Eduardo Pásaro, Nuria Arias-Ramos, Pilar López-Larrubia, Maria P De Miguel

Förderung

  • Spanish Ministry of Science.
  • Spanish Ministry of Science

Zitieren

APA

Marcos, A., Rodríguez Del Cerro, M. C., Fernández, R. M., Pásaro, E., Arias-Ramos, N., López-Larrubia, P., González-Peramato, P., Guillamon, A., & De Miguel, M. P. (2025). The GnRH Agonist Triptorelin Causes Reversible, Focal, and Partial Testicular Atrophy in Rats, Maintaining Sperm Production. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146566

Vancouver

Marcos A, Rodríguez Del Cerro MC, Fernández RM, Pásaro E, Arias-Ramos N, López-Larrubia P, et al. The GnRH Agonist Triptorelin Causes Reversible, Focal, and Partial Testicular Atrophy in Rats, Maintaining Sperm Production. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146566

BibTeX
@article{Marcos2025,
  author = {Marcos, Alberto and Rodríguez Del Cerro, Maria Cruz and Fernández, Rosa María and Pásaro, Eduardo and Arias-Ramos, Nuria and López-Larrubia, Pilar and González-Peramato, Pilar and Guillamon, Antonio and De Miguel, Maria P},
  title = {The GnRH Agonist Triptorelin Causes Reversible, Focal, and Partial Testicular Atrophy in Rats, Maintaining Sperm Production},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146566}
}
Kostenlos starten →